NVO

Novo Nordisk ADR

46.60

Sep 04 • 3:59 PM ET -0.91 (-1.92%)

46.55

Aftermarket • 7:59 PM ET -0.05 (-0.11%)

Healthcare Drug Manufacturers - General Denmark Large NYSE

Peers: LLY AZN MRK PFE ABBV JNJ NVS BMY SNY AMGN

| Held by: AVDE PPH CNEQ WCMI PID AVIV APIE OZEM IDVO FENI

Scroll to Statements

Index	-
Market Cap	155.92B
Enterprise Value	170.47B
Income	18.19B
Sales	51.45B
Book/sh	7.66
Cash/sh	2.06
Dividend Est.	1.82 (3.91%)
Dividend TTM	1.80 (3.85%)
Dividend Ex-Date	Aug 17, 2026
Dividend Gr. 3/5Y	26.98% 19.93%
Payout	36.87%
Employees	68794
IPO	Apr 30, 1981

P/E	11.39
Forward P/E	13.99
PEG	-
P/S	3.03
P/B	6.09
P/C	22.66
P/FCF	13.22
EV/EBITDA	6.42
EV/Sales	3.31
Quick Ratio	0.66
Current Ratio	0.87
Debt/Eq	0.63
LT Debt/Eq	0.55
Option/Short	Yes / Yes

EPS (ttm)	4.09
EPS next Y	3.33
EPS next Q	0.77
EPS this Y	-6.50%
EPS next Y	-2.06%
EPS next 5Y	-0.05%
EPS past 3/5Y	26.28% 20.36%
Sales past 3/5Y	23.19% 19.21%
EPS Y/Y TTM	12.68%
Sales Y/Y TTM	13.21%
EPS Q/Q	-18.69%
Sales Q/Q	4.59%
Earnings	Aug 04 AMC
EPS/Sales Surpr.	24.09% 11.40%

Insider Own	0.01%
Insider Trans	0.00%
Inst Own	9.89%
Inst Trans	-0.16%
ROA	21.81%
ROE	60.35%
ROIC	34.67%
Gross Margin	80.65%
Oper. Margin	45.38%
Profit Margin	35.36%
SMA20	0.23%
SMA50	-2.69%
SMA200	0.55%
Trades

Shs Outstand	3.35B
Shs Float	3.35B
Short Float	1.01%
Short Ratio	2.79
Short Interest	33.83M
52W High	64.16 -27.37%
52W Low	35.12 32.69%
Volatility	2.18% 2.11%
ATR (14)	1.38
RSI (14)	49.14
Beta	0.75
Rel Volume	0.51
Avg Volume	12.12M
Volume	6,219,256

Perf Week	2.17%
Perf Month	1.37%
Perf Quarter	8.47%
Perf Half Y	20.79%
Perf YTD	-8.41%
Perf Year	-16.99%
Perf 3Y	-50.77%
Perf 5Y	-7.62%
Perf 10Y	103.49%
Recom	2.80
Target Price	44.50
Prev Close	47.51
Price	46.60
Change %	-1.92%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-27-26	Downgrade	Deutsche Bank	Hold → Sell
Aug-12-26	Downgrade	Berenberg	Buy → Hold
Mar-26-26	Initiated	Wolfe Research	Peer Perform
Mar-18-26	Initiated	Bernstein	Underperform
Mar-18-26	Initiated	Bernstein	Outperform	$175
Mar-10-26	Downgrade	TD Cowen	Buy → Hold	$42
Mar-03-26	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$40
Mar-02-26	Downgrade	Goldman	Buy → Neutral	$41
Feb-24-26	Downgrade	Kepler	Buy → Hold
Feb-24-26	Downgrade	JP Morgan	Overweight → Neutral
Feb-23-26	Downgrade	Deutsche Bank	Buy → Hold
Feb-12-26	Upgrade	Jefferies	Underperform → Hold
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform

Show Previous Ratings

Today 01:50PM	Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial Cancellations (GuruFocus.com)
08:08AM	Novo Nordisk Semaglutide Trial Shows 40.4% of Children Moved Below Obesity BMI Threshold (InvestorsHub)
06:00AM	Weight loss is just the beginning of GLP-1's: Novo Nordisk CEO (Yahoo Finance Video)
Sep-05-26 08:30AM	Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze. (MarketWatch)
Sep-04-26 01:09PM	Novo Nordisk Falls 2% as Wegovy Opens a German Front (GuruFocus.com)
10:30AM	Loading…
Sep-02-26 10:30AM	Citi flags GLP-1 prescription slowdown at Novo Nordisk, reiterates 'sell' (Proactive)
08:05AM	Peptide innovator says the drug class is due for a rethink (Pharmaceutical Technology)
12:36AM	HIMS Stock Kicks Off September In The Red: FDAs GLP-1 Alert Steals The Spotlight From Australia Expansion (Stocktwits)
Sep-01-26 01:28PM	Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in Germany (GuruFocus.com)
05:19AM	A leadership gap looms in Nordic and Benelux boardrooms (Fortune)
Aug-31-26 06:08PM	Chris Benecchi Named Inventivas New Chief Operating Officer (Exec Edge)
08:55AM	Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market (NASDAQ: ENTX) (FinanceWire)
Aug-28-26 01:50PM	Novo's Wegovy Pill Enters China Behind Lilly (GuruFocus.com)
01:40PM	Eli Lilly's diabetes drug Mounjaro gets approval for a new use (USA TODAY)
10:12AM	Mounjaro Just Opened a Much Bigger Door (GuruFocus.com)
03:32PM	Loading…
Aug-27-26 03:32PM	Novo Sends Oral Wegovy Into China's GLP-1 Race Behind Lilly (GuruFocus.com)
01:46PM	Novo Nordisk files for oral weight loss pill approval in China (Quartz)
01:46PM	Novo Nordisk is seeking Chinese approval for its oral weight loss pill (Quartz)
11:46AM	Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren't the Reason (Barrons.com)
09:22AM	Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip (Investing.com)
08:30AM	GLP-1 maker hit with 'sell' rating as 2027 revenue cliff fears mount (Proactive)
07:25AM	Pharmas new CEOs to watch (Pharma Voice)
07:05AM	Novos 2027 Growth Rebound Faces Fresh Doubts From Deutsche Bank Even As China Wegovy Milestone Offers Retail Hope (Stocktwits)
04:37AM	Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak (MarketWatch)
Aug-26-26 06:48AM	Boston Scientific hit by cyberattack, global operations affected (Reuters)
Aug-25-26 12:41PM	European shares gain on softer US Iran sanctions, falling oil prices (Reuters)
Aug-24-26 01:27PM	LXRX Stock Edges Higher On $10M Payout From Novo Nordisk Retail Traders Highlight More Cash Milestones On The Horizon (Stocktwits)
08:54AM	Lilly's GLP-1 pill hits UK pharmacies as US battle with Novo intensifies (Proactive)
07:13AM	Eli Lilly Launches Foundayo Weight-Loss Pill in UK (InvestorsHub)
05:47AM	Roche commits to lean-mass preservation with Hanmi obesity deal (BioPharma Dive)
05:42AM	Loading…
05:42AM	3 potential blockbusters beyond obesity to watch (Pharma Voice)
Aug-21-26 05:50PM	SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing (Stocktwits)
Aug-19-26 06:38AM	Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy A Look At Some Key Highlights (Stocktwits)
06:30AM	HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation (TMX Newsfile)
03:28AM	How cost and perception could reshape the GLP-1 market (Pharma Voice)
Aug-18-26 11:32AM	Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" (Investing.com)
02:17AM	Tech Weekly: soccer bots and balloon rockets (Reuters Videos)
Aug-17-26 07:01AM	Novo Nordisk AS's Dividend Analysis (GuruFocus.com)
Aug-13-26 02:38PM	Novo Nordisk Stock Slips as Pill Strategy Reframes Obesity Race (GuruFocus.com)
01:32PM	Novo Nordisk Escalates Weight-Loss War With Eli Lilly (GuruFocus.com)
Aug-12-26 10:36PM	Novo Nordisk CEO Concedes Eli Lillys Market-Share Gains as Stock Slumps (BeInCrypto)
01:29PM	Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market (GuruFocus.com)
09:07AM	Eli Lilly is suing pharmacies and peptide vendors over premature sales of the next big weight-loss drug: retatrutide (MarketWatch)
Aug-11-26 03:07PM	Eli Lilly Scores Major Win in Weight-Loss Drug Race (GuruFocus.com)
11:12AM	Lilly Takes Its Weight-Loss Pill Battle Overseas (GuruFocus.com)
07:26AM	UK regulators greenlight Lillys Foundayo, intensifying Novo competition (Pharmaceutical Technology)
Aug-10-26 05:58PM	Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough. (Barrons.com)
05:21AM	Did Novos phase 3 flop kill the inflammation hypothesis in heart disease? (Pharma Voice)
01:00AM	Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs (Barrons.com)
Aug-07-26 03:52PM	Novo Nordisk Stock Rises After GLP-1 Antitrust Win (GuruFocus.com)
12:34PM	Lilly and Novo Win a Key GLP-1 Antitrust Fight (GuruFocus.com)
06:41AM	The Week in Numbers: BP's huge profit, Toyota moves fast (Reuters Videos)
Aug-06-26 07:18PM	Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ... (GuruFocus.com)
01:19PM	Amazon Takes Bold Step Beyond Retail (GuruFocus.com)
01:04PM	Amazon Is Bringing the Weight-Loss Drug Race to Medicare (GuruFocus.com)
08:31AM	Weight-loss drug Wegovy made Novo Nordisk Europes most valuable company. Finding its next blockbuster drug is proving difficult (Fortune)
07:30AM	33 stocks to bet on foreign markets continuing to beat the S&P 500 (MarketWatch)
07:18AM	Eli Lilly raises 2026 outlook again as Q2 soars past estimates (Pharmaceutical Technology)
Aug-05-26 03:46PM	Eli Lilly stock jumps as GLP-1 sales widen Novo lead (InvestorsHub)
02:30PM	Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook (GuruFocus.com)
01:33PM	Stocks mixed with Nasdaq down; gold prices jump (Reuters)
12:52PM	How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? (MarketWatch)
12:22PM	Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says (Pharmaceutical Technology)
11:06AM	Novo Nordisk Swallows the Bitter Pill (Moby)
11:02AM	Eli Lilly is treating nearly 10% of US obesity population with GLP-1s: CFO (Yahoo Finance Video)
09:19AM	Novo Nordisk looks to future proof as investors worry over pipeline (Reuters Videos)
08:01AM	Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars (Financial Times)
07:11AM	CVS shares jump on earnings beat, raised full-year guidance (Investing.com)
07:05AM	Eli Lilly raises annual revenue forecast as obesity, diabetes drug demand stay strong (Reuters)
07:04AM	Lilly's revenue soars 48%, driven by demand of its GLP-1s (MarketWatch)
06:50AM	Novo Nordisk shares fall despite improved outlook as Wegovy sales disappoint (InvestorsHub)
05:26AM	Middle East optimism lifts sentiment as SpaceX and AMD earnings dominate attention: Dow Jones, S&P, Nasdaq, Wall Street Futures (InvestorsHub)
05:18AM	European shares hover near record highs as earnings offset Mideast uncertainty (Reuters)
03:23AM	Novo Nordisk tumbles as Wegovy sales miss, trial setback overshadow raised outlook (Investing.com)
02:17AM	FTSE 100 Live: Next and Glencore provide results boost, SpaceX tumbles (Proactive)
Aug-04-26 04:01PM	The Wegovy pill's 'surprise miss' is one reason Novo Nordisk's stock is down (MarketWatch) -5.97%
04:00PM	NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales Future (Stocktwits)
02:20PM	Novo Nordisk Stock Drops on Wegovy Shortfall (The Wall Street Journal)
02:16PM	Novo Nordisk Raises Earnings Guidance. The Stock Sinks. (Barrons.com)
01:40PM	Novo Nordisk Q2 2026 earnings beat, raises full-year outlook (Quartz)
12:51PM	Novo Nordisk: Q2 Earnings Snapshot (Associated Press)
12:00AM	Arrogance kills: Novo chief injects risk-taking into Ozempic maker (Financial Times)
Aug-03-26 11:02AM	Citi says Novo selloff overdone but GLP-1 worries keep it on the sidelines (Proactive)
10:55AM	Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison (IPO-Edge.com)
09:04AM	Earnings live updates: Snap stock surges as World Cup ads boost revenue, Whirlpool falls (Yahoo Finance)
Jul-31-26 08:52PM	NVO Stock Ends Three-Month Winning Streak As Novo Nordisks Key Heart Drug Flops, Competition Goes To Court (Stocktwits) -8.78%
05:56PM	BIOA, GLUE Stocks Clock Worst Day In Years Whats The NVO Connection? (Stocktwits)
04:50PM	Novo Nordisk stock sinks 9% as heart drug fails trial (InvestorsHub)
10:56AM	Novo Nordisk Stock Drops as Heart Drug Fails Late-Stage Trial (Barrons.com)
10:46AM	Novo Nordisk Suffers Another Pipeline Setback (GuruFocus.com)
10:44AM	Novo Nordisk Stock Falls 7% as ZEUS Trial Fails (GuruFocus.com)
09:54AM	Novo Nordisk's stock slumps after failed trial - adding to the company's woes (MarketWatch)
09:36AM	NVO Stock Slumps After Late-Stage Trial Fails Primary Goal Retail Says Current Revenue Drivers Still Intact (Stocktwits)
08:51AM	Novo Nordisk Stock Sinks on Disappointing Heart Drug Trial Results (Investopedia)
08:46AM	Novo Nordisk ziltivekimab heart drug fails phase 3 trial (Quartz)
08:35AM	Novo Nordisk Stock Drops After Drug Fails in Cardiovascular Trial (The Wall Street Journal)
08:31AM	Novo Nordisk Stock Tumbles on Late-Stage Trial Results (Schaeffer's Research)
08:05AM	Novo Nordisk stock tumbles 10% as key trial misses goal (Investing.com)
Jul-24-26 09:09AM	As Lilly and Novo Clash in Court, Wall Street Is Eyeing This Bigger Prize (Barrons.com)
08:31AM	Novo Nordisk Seeks Injunction Against Eli Lilly Weight-Loss Ads (GuruFocus.com)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Executive VPMr. Karsten Munk Knudsen

PresidentMr. Maziar Mike Doustdar B.A.

EVP of R&DDr. Martin Holst Lange

EVP of PeopleMs. Tania Sabroe

Executive VP of Enterprise IT & Quality and Member of Management BoardMs. Thilde Hummel Bogebjerg

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your Finviz experience